Ruian Gene Lymphoma Kit is expected to complete clinical registration research in one year.
Ruian Gene stated that the company's lymphoma kit in cooperation with Ruijin Hospital has launched a large-scale study of 1,002 cases and is cooperating with pharmaceutical companies for clinical trials. The registration study is expected to be completed clinically within one year. The company stated that the project has also been recognized by the Food and Drug Administration and , and may set a precedent without a fixed-site kit approval process. The leukemia test kit has also completed the registration point, and clinical trials will be launched probably in the second half of the year. ( Science and Technology Innovation Board Daily)
For more hot information, insight analysis, research reports, live lectures... Please pay attention to [Hard Technology]
Welcome to search [Hard Technology] on all major platforms and look for accounts with blue logos!
is here to see, understand and connect with hard technology! We focus on optoelectronic chips, artificial intelligence , aerospace, new energy, smart cars, biomedicine , science and technology finance and other industries, and rely on the unique scientific and technological intelligence data advantages of the scientific and technological innovation intelligence SaaS service provider Wisdom Ya, See technology trends with readers, understand the hard technology industry, and connect to the innovative future. "Hard Technology" is produced by the Smart Bud Innovation Research Center.
